Stoke Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 6.2M | 1.4M | 10.6M | 13.8M | 158.6M | 22.6M | 4.9M | 4.8M |
| Cost of Goods Sold | 1.0M | 1.1M | 989K | 0 | 0 | 0 | 0 | 1.1M |
| Gross Profit | 5.2M | 347K | 9.6M | 13.8M | 158.6M | 22.6M | 4.9M | 3.7M |
| R&D Expenses | 39.7M | 41.3M | 37.3M | 25.9M | 32.7M | 23.4M | 22.2M | 20.6M |
| Operating Expenses | 58.6M | 61.8M | 52.7M | 41.1M | 47.3M | 36.3M | 34.9M | 33.1M |
| Operating Income | -53.4M | -61.4M | -43.1M | -27.3M | 111.2M | -13.7M | -30.0M | -29.3M |
| Other Income / Gains | 3.4M | 3.5M | 3.5M | 3.8M | 2.9M | 3.2M | 3.6M | 3.6M |
| Net Income | -50.0M | -57.9M | -38.3M | -23.5M | 112.9M | -10.5M | -26.4M | -25.7M |
| EPS (Diluted) | -0.79 | -0.99 | -0.65 | -0.40 | 1.95 | -0.18 | -0.47 | -0.46 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.832 | 0.248 | 0.907 | 1.00 | 1.00 | 1.00 | 1.00 | 0.77 |
| General And Administrative Expenses | 0 | 0 | 0 | 15.3M | 14.7M | 12.8M | 12.7M | 13.0M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -562K |
| Selling General And Administrative Expenses | 20.0M | 20.5M | 15.5M | 15.3M | 14.7M | 12.8M | 12.7M | 12.5M |
| Other Expenses | -1.0M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 59.6M | 62.8M | 53.7M | 41.1M | 47.3M | 36.3M | 34.9M | 34.2M |
| Interest Income | 0 | 3.6M | 3.5M | 3.8M | 2.9M | 3.0M | 3.5M | 3.7M |
| Interest Expense | 3.4M | 3K | 3K | 3K | 1K | 0 | 0 | 0 |
| Depreciation And Amortization | 1.0M | 1.1M | 989K | 446K | 477K | 526K | 540K | 548K |
| Ebitda | -45.6M | -56.9M | -38.6M | -23.0M | 114.6M | -10.0M | -25.9M | -25.1M |
| Ebitdaratio | -7.314 | -40.568 | -3.634 | -1.667 | 0.723 | -0.44 | -5.29 | -5.205 |
| Operating Income Ratio | -8.576 | -43.822 | -4.053 | -1.976 | 0.702 | -0.604 | -6.131 | -6.074 |
| Income Before Tax | -50.0M | -57.9M | -39.6M | -23.5M | 114.2M | -10.5M | -26.4M | -25.7M |
| Income Before Tax Ratio | -8.027 | -41.322 | -3.727 | -1.70 | 0.72 | -0.464 | -5.40 | -5.319 |
| Income Tax Expense | 0 | 0 | -1.3M | 0 | 1.3M | 0 | 0 | 0 |
| Net Income Ratio | -8.027 | -41.322 | -3.607 | -1.70 | 0.712 | -0.464 | -5.40 | -5.319 |
| Epsdiluted | -0.79 | -0.99 | -0.65 | -0.40 | 1.90 | -0.18 | -0.47 | -0.46 |
| Weighted Average Shs Out | 63.1M | 58.4M | 58.6M | 58.4M | 57.9M | 57.0M | 56.3M | 55.8M |
| Weighted Average Shs Out Dil | 63.1M | 58.4M | 58.6M | 58.4M | 59.4M | 57.0M | 56.3M | 55.8M |